Cardiac resynchronization therapy in heart failure based on Strauss criteria for left bundle branch block.
CRT response
Strauss LBBB
ischaemic cardiomyopathy
non‐ischaemic cardiomyopathy
ventricular arrhythmias
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
20 Sep 2024
20 Sep 2024
Historique:
revised:
31
07
2024
received:
24
04
2024
accepted:
02
08
2024
medline:
20
9
2024
pubmed:
20
9
2024
entrez:
20
9
2024
Statut:
aheadofprint
Résumé
The left bundle branch block (LBBB) is a strong predictor of response to cardiac resynchronization therapy (CRT). However, a significant number of patients do not respond to the treatment. The study sought to evaluate the impact of the stricter Strauss criteria for left bundle branch block (St-LBBB) on CRT response, hospitalizations, ventricular arrhythmia (VA) events and mortality. This study is a retrospective analysis of prospectively collected data on heart failure (HF) patients with LBBB admitted for CRT implantation. Patients were divided into two groups according to the fulfilment or not of St-LBBB criteria. The study included 82 patients with ischaemic (ICM) and non-ischaemic (NICM) cardiomyopathy [46 (56%) with St-LBBB and 36 (44%) with non-St-LBBB]. Patients with St-LBBB showed higher CRT response rates compared with those with non-St-LBBB (P < 0.01), while the group with NICM exhibited the greatest benefit (P < 0.01). St-LBBB CRT responders displayed significantly lower rates of HF hospitalization (P < 0.0001) compared with the non-St-LBBB group. According to Kaplan-Meier time curves, this was primarily evident in patients with NICM (P < 0.0001). CRT responders displayed significantly fewer VA events (P < 0.001) and lower mortality rates (P < 0.0001) than non-responders. Kaplan-Meier estimates demonstrated a significantly lower incidence of VAs in NICM patients with St-LBBB (P = 0.049) compared with ICM patients with St-LBBB (P = 0.25). Lower mortality rates were observed in CRT responders than non-responders (P < 0.0001), with the group of NICM with St-LBBB criteria exhibiting the greatest benefit (P = 0.0238). Patients with NICM and St-LBBB present the greatest benefit concerning CRT response, HF hospitalizations, VA events and mortality. Although St-LBBB criteria seem to improve patient selection for CRT, more data are needed to elucidate the role of St-LBBB criteria in this setting.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
Prinzen FW, Vernooy K, Auricchio A. Cardiac resynchronization therapy. Circulation 2013;128:2407‐2418. doi:10.1161/CIRCULATIONAHA.112.000112
Birnie DH, Tang AS. The problem of non‐response to cardiac resynchronization therapy. Curr Opin Cardiol 2006;21:20–26. doi:10.1097/01.hco.0000198983.93755.99
Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2021;42:3427–3520. doi:10.1093/eurheartj/ehab364
Bertaglia E, Migliore F, Baritussio A, de Simone A, Reggiani A, Pecora D, et al. Stricter criteria for left bundle branch block diagnosis do not improve response to CRT. Pacing Clin Electrophysiol 2017;40:850–856. doi:10.1111/pace.13104
Tian Y, Zhang P, Li X, Gao Y, Zhu T, Wang L, et al. True complete left bundle branch block morphology strongly predicts good response to cardiac resynchronization therapy. EP Europace 2013;15:1499–1506. doi:10.1093/europace/eut049
Mugnai G, Donazzan L, Tomasi L, Piccoli A, Cavedon S, Manfrin M, et al. Electrocardiographic predictors of echocardiographic response in cardiac resynchronization therapy: Update of an old story. J Electrocardiol 2022;75:36–43. doi:10.1016/j.jelectrocard.2022.10.001
García‐Seara J, Iglesias Alvarez D, Alvarez Alvarez B, Gude Sampedro F, Martínez Sande JL, Rodríguez‐Mañero M, et al. Cardiac resynchronization therapy response in heart failure patients with different subtypes of true left bundle branch block. J Interv Card Electrophysiol 2018;52:91–101. doi:10.1007/s10840‐018‐0363‐x
Hadjis A, AlTurki A, Proietti R, Montemezzo M, Bernier M, Joza J, et al. Predicting response to cardiac resynchronization therapy: Use of strict left bundle branch block criteria. Pacing Clin Electrophysiol 2019;42:431–438. doi:10.1111/pace.13638
Caputo ML, van Stipdonk A, Illner A, D'Ambrosio G, Regoli F, Conte G, et al. The definition of left bundle branch block influences the response to cardiac resynchronization therapy. Int J Cardiol 2018;269:165–169. doi:10.1016/j.ijcard.2018.07.060
Tomassoni G. How to define cardiac resynchronization therapy response. Journal of Innovations in Cardiac Rhythm Management 2016;7:S1–S7. doi:10.19102/icrm.2016.070003
Strauss DG, Selvester RH, Wagner GS. Defining left bundle branch block in the era of cardiac resynchronization therapy. Am J Cardiol 2011;107:927–934. doi:10.1016/j.amjcard.2010.11.010
Morgan JM, Delgado V. Lead positioning for cardiac resynchronization therapy: Techniques and priorities. Europace 2009;11:v22–v28. doi:10.1093/europace/eup306
Martin DO, Lemke B, Birnie D, Krum H, Lee KL‐F, Aonuma K, et al. Investigation of a novel algorithm for synchronized left‐ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: Results of the adaptive CRT trial. Heart Rhythm 2012;9:1807–1814.e1. doi:10.1016/j.hrthm.2012.07.009
Singh JP, Abraham WT, Chung ES, Rogers T, Sambelashvili A, Coles JA, et al. Clinical response with adaptive CRT algorithm compared with CRT with echocardiography‐optimized atrioventricular delay: A retrospective analysis of multicentre trials. Europace 2013;15:1622–1628. doi:10.1093/europace/eut107
Stiles MK, Fauchier L, Morillo CA, Wilkoff BL, ESC Scientific Document Group. HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter‐defibrillator programming and testing. Europace 2019;2019:1442–1443. doi:10.1093/europace/euz065
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599–3726. doi:10.1093/eurheartj/ehab368
Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J, Misier AR, et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003;42:2109–2116. doi:10.1016/j.jacc.2003.04.003
Singh JP, Berger RD, Doshi RN, Lloyd M, Moore D, Daoud EG, et al. Rationale and design for ENHANCE CRT: QLV implant strategy for non‐left bundle branch block patients. ESC Heart Fail 2018;5:1184–1190. doi:10.1002/ehf2.12340
Singh JP, Berger RD, Doshi RN, Lloyd M, Moore D, Stone J, et al. Targeted left ventricular lead implantation strategy for non‐left bundle branch block patients: The ENHANCE CRT study. JACC Clin Electrophysiol 2020 Sep;6:1171–1181. doi:10.1016/j.jacep.2020.04.034
Gold MR, Singh JP, Ellenbogen KA, Yu Y, Wold N, Meyer TE, et al. Interventricular electrical delay is predictive of response to cardiac resynchronization therapy. JACC Clin Electrophysiol. 2016 Aug;2:438–447. doi:10.1016/j.jacep.2016.02.018
Auricchio A, Fantoni C, Regoli F, Carbucicchio C, Goette A, Geller C, et al. Characterization of left ventricular activation in patients with heart failure and left bundle‐branch block. Circulation 2004;109:1133–1139. doi:10.1161/01.CIR.0000118502.91105.F6
Tung R, Sung W, Shatz N, Upadhyay GA. High resolution mapping of LV activation during left bundle brunch block: Correlation of transseptal breakthrough and Strauss criteria. Heart Rhythm 2021;18:S174. doi:10.1016/j.hrthm.2021.06.439
Tankut S, Goldenberg I, Kutyifa V, Zareba W, Bragazzi NL, McNitt S, et al. Cardiac resynchronization therapy and ventricular tachyarrhythmia burden. Heart Rhythm 2021;18:762–769. doi:10.1016/j.hrthm.2020.12.034
di Biase L, Gasparini M, Lunati M, Santini M, Landolina M, Boriani G, et al. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy. J Am Coll Cardiol 2008;52:1442–1449. doi:10.1016/j.jacc.2008.07.043
Linde C, Abraham WT, Gold MR, St. John Sutton M, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834–1843. doi:10.1016/j.jacc.2008.08.027
Ruwald MH, Solomon SD, Foster E, Kutyifa V, Ruwald A‐C, Sherazi S, et al. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes. Circulation 2014;130:2278–2286. doi:10.1161/CIRCULATIONAHA.114.011283
Higgins SL, Yong P, Scheck D, McDaniel M, Bollinger F, Vadecha M, et al. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000;36:824–827. doi:10.1016/S0735‐1097(00)00795‐6
Barsheshet A, Wang PJ, Moss AJ, Solomon SD, Al‐Ahmad A, McNitt S, et al. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT‐CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy). J Am Coll Cardiol 2011;57:2416–2423. doi:10.1016/j.jacc.2010.12.041
Gasparini M, Mantica M, Galimberti P, Genovese L, Pini D, Faletra F, et al. Is the outcome of cardiac resynchronization therapy related to the underlying etiology? Pacing Clin Electrophysiol 2003;26:175–180. doi:10.1046/j.1460‐9592.2003.00011.x
St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985–1990. doi:10.1161/01.CIR.0000065226.24159.E9
Sciagrà R, Giaccardi M, Porciani MC, Colella A, Michelucci A, Pieragnoli P, et al. Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. J Nucl Med 2004;45:164–168.
Fish JM, Brugada J, Antzelevitch C. Potential proarrhythmic effects of biventricular pacing. J Am Coll Cardiol 2005;46:2340–2347. doi:10.1016/j.jacc.2005.08.035
Celikyurt U, Agacdiken A, Sahin T, Al N, Kozdag G, Vural A, et al. Number of leads with fragmented QRS predicts response to cardiac resynchronization therapy. Clin Cardiol 2013;36:36–39. doi:10.1002/clc.22061
Das MK, Suradi H, Maskoun W, Michael MA, Shen C, Peng J, et al. Fragmented wide QRS on a 12‐lead ECG. Circ Arrhythm Electrophysiol 2008;1:258–268. doi:10.1161/CIRCEP.107.763284
Das MK, Zipes DP. Fragmented QRS: A predictor of mortality and sudden cardiac death. Heart Rhythm 2009;6:S8–S14. doi:10.1016/j.hrthm.2008.10.019